Dr. Cathrine Hoyo's lab at North Carolina State University focuses on understanding how prenatal stress and diet influence children's health, especially regarding obesity and metabolic disorders. By studying epigenetic changes that occur due to environmental factors, such as maternal stress and dietary habits, the lab aims to identify potential interventions that can mitigate negative health outcomes. Additionally, they investigate how exposure to environmental contaminants affects liver health, particularly in southern states where rates of liver cancer are rising.

Dr. Stefan Prokop's lab at the University of Florida focuses on understanding how certain proteins in the brain contribute to Alzheimer's disease (AD). They are investigating the role of amyloid-associated proteins (AAPs) in the progression of the disease, particularly how these proteins might affect neurodegeneration over time. By studying these processes, the lab aims to identify potential new therapeutic targets to combat AD and improve patient outcomes.

Dr. Or P. Gozani's lab at Stanford University studies how protein methylation affects cell biology and contributes to diseases. They focus on modifications that happen on proteins, especially those related to chromatin and gene expression. This research aims to uncover the roles of specific enzymes involved in these processes, which may lead to new treatments for various health issues.

Dr. Stephen K. Burley's lab at Rutgers University focuses on managing and enhancing the Protein Data Bank (PDB), which stores important information about the 3D structures of proteins and nucleic acids. Their work ensures that scientists around the world have free access to this crucial data, helping them understand biological processes and diseases. The lab is committed to improving data quality and making new structure determination methods available to the research community.

Dr. Steven P Gygi's lab at Harvard Medical School focuses on innovative techniques for studying proteins, which are crucial molecules in biological processes. His research aims to improve methods for analyzing protein levels and modifications in various conditions, helping to define protein functions and discover potential therapies for diseases. The lab is particularly known for advancing sample multiplexing technologies that allow for efficient analysis of multiple protein samples simultaneously.

Dr. John D Mccorvy's lab focuses on exploring the pharmacological potential of psychedelics, particularly their effects on mental health disorders like depression. By designing and developing new chemical probes specifically targeting serotonin receptors, the lab aims to differentiate between the therapeutic effects and the psychedelic experiences, paving the way for innovative treatments in psychiatry. Their research combines both structure-based drug design and an in-depth understanding of signaling pathways related to serotonin receptors.

The research lab of Dr. Pudur Jagadeeswaran at the University Of North Texas focuses on understanding how genes influence the development of blood platelets from megakaryocytes, specifically using zebrafish as a model. By examining the genetic mechanisms involved in thrombopoiesis, the lab aims to uncover key factors that could help address conditions like thrombocytopenia, a disorder characterized by low platelet counts. The research not only advances basic biology but also has potential implications for improving treatments for blood-related diseases.

Joseph D Puglisi's lab at Stanford University focuses on understanding how protein translation works, especially in relation to neurodegenerative diseases like Alzheimer's and ALS. They look into an unusual form of translation called RAN translation, which can lead to the production of harmful proteins when certain genetic sequences are repeated too many times. By combining techniques from biophysics and genetics, the lab aims to uncover how translation mechanisms can go awry and what can be done to mitigate their effects on health.

Dr. Nagireddy Putluri's research lab at Baylor College of Medicine focuses on understanding bladder cancer, a disease with significant variation in patient outcomes. The lab investigates how genetic alterations, particularly related to a gene called EPHX2, influence tumor behavior and response to treatments. By analyzing molecular and metabolic changes in tumors, they aim to develop new therapeutic strategies that combine targeting cancer metabolism with immunotherapy to improve patient care.

Dr. Qian Cai's lab at Rutgers University focuses on understanding the molecular mechanisms behind tauopathies, particularly in Alzheimer's disease. They investigate how communication between cellular organelles, like mitochondria and autophagosomes, impacts the buildup of toxic tau protein and neuronal health. This research aims to identify potential therapeutic targets for treating Alzheimer's and other neurodegenerative diseases.

Dr. Xuebin Qin's research focuses on understanding the roles of renal macrophages and the complement system in kidney diseases and severe COVID-19. In particular, they are studying how signaling pathways affect the behavior and longevity of renal macrophages, which are critical for kidney health. The lab also investigates how the complement system contributes to blood vessel damage during severe COVID-19 and explores potential therapies to mitigate these effects.

Dr. Arthur M. Mercurio's lab focuses on understanding and overcoming resistance to radiation therapy in triple negative breast cancer (TNBC). The lab aims to explore how the interaction between vascular endothelial growth factor (VEGF) and its receptor, neuropilin-2 (NRP2), contributes to radiation resistance. By leveraging patient-derived models and organoids, the team seeks to discover novel therapies that enhance the effectiveness of radiotherapy in treating aggressive forms of breast cancer.

Dr. Rajagopal Ramesh's lab focuses on innovative cancer treatments using advanced drug delivery systems and immune modulation techniques. They explore how exosomes, small vesicles released by cells, can carry cancer medications directly to tumors to improve treatment effectiveness and reduce side effects. The lab's research also investigates ways to combine these treatments with immune checkpoint inhibitors to enhance the body’s immune response against lung cancer.

Dr. Aleksandar Rajkovic's lab at UCSF focuses on improving access to genomic healthcare, especially for underserved communities. They are implementing an innovative electronic consultation network called WestGEN, which connects healthcare providers with genetic specialists. This project not only enhances provider training in genomics but also explores the use of artificial intelligence to streamline these consultations, ultimately aiming to improve patient outcomes and health equity.

Dr. Parameswaran Ramakrishnan's lab focuses on understanding the role of a protein called Sam68 in inflammatory bowel disease, particularly ulcerative colitis. The lab investigates how Sam68 signaling affects immune responses in the intestinal epithelial cells, aiming to identify new therapeutic approaches to treat this chronic condition. By exploring both human and mouse models, including advanced techniques such as organoids, the research seeks to uncover mechanisms that contribute to inflammation and potential treatment targets.

Dr. Sharad Ramanathan's lab at Harvard University focuses on understanding how specific cells in the human brain, called astrocytes, develop and function. They create advanced models of the human brain using stem cells to explore the genetic and environmental factors that influence brain development. Ultimately, this research aims to improve our understanding of various brain diseases and may help develop new treatments.

Dr. Gwendalyn J Randolph's lab focuses on understanding and treating intestinal failure-associated liver disease (IFALD), especially in pediatric patients suffering from short gut syndrome and inflammatory bowel diseases. The research involves investigating how specific signaling pathways in the intestines and lymphatic systems contribute to these conditions and exploring potential therapeutic approaches using novel compounds. By combining studies in mouse models and piglet models, the lab aims to translate their findings into effective treatments for children.

Dr. Venigalla Rao's lab focuses on developing innovative therapies to combat HIV, particularly for vulnerable populations such as substance users. They are engineering a unique type of virus called bacteriophage T4 to deliver genetic changes to patients' own stem cells, making them resistant to HIV. This exciting approach could lead to affordable and effective treatments for HIV that work by replacing infected cells with healthy, HIV-resistant cells.

Dr. Elaine F Reed's lab focuses on understanding the immune system's responses in organ transplant recipients, particularly how immunosuppressive therapies affect vaccine efficacy and transplant rejection. They are exploring the immune responses to SARS-CoV-2 vaccines in kidney transplant patients, investigating how specific treatment regimens influence immunity. Additionally, the lab examines the molecular mechanisms that lead to graft rejection and finds innovative ways to enhance transplant outcomes.

Dr. Wade G. Regehr's lab at Harvard Medical School studies the complex circuitry of the cerebellum, focusing on how different types of neurons contribute to its functions. The lab examines how these neurons process signals and influence behaviors, such as motor control and social interactions. By upgrading our understanding of cerebellar circuits, the research aims to shed light on cerebellar disorders and their effects on neurological health.